Aczone Gel
Product Images NDC 0023-3670

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Aczone (NDC 0023-3670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aczone 5 01

Aczone 5 01
Chemical structure of dapsone, showing two benzene rings connected by a sulfone (SO2) group, each ring with an amine (NH2) group attached.*
FDA Label Image

Aczone 5 02

FDA Label Image

Aczone 5 03

Aczone 5 03
ACZONE dapsone 50 mg/g topical gel carton from Allergan, Inc. The white box shows the product name ACZONE in large letters and indicates the active ingredient dapsone at 50 mg/g strength. This prescription drug is for topical use as a gel. The label includes Allergan's logo and the NDC 0023-3670.*
FDA Label Image

Aczone 5 04

FDA Label Image

Aczone 5 05

Aczone 5 05
Packaging label for ACZONE (dapsone) gel 5%, a topical prescription gel by Allergan, Inc. The label identifies the product strength as 5% dapsone gel and indicates a package size of 90 grams. The label includes dosage instructions, storage conditions, barcode, and manufacturer information, emphasizing topical use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.